Peer Review reports
From: Associated risk factors with disease severity and antiviral drug therapy in patients with COVID-19
| Original Submission | ||
|---|---|---|
| 2 Sep 2020 | Submitted | Original manuscript |
| 4 Oct 2020 | Reviewed | Reviewer Report |
| 10 Oct 2020 | Reviewed | Reviewer Report - KHALID AHMAD ALSUNAIDAR |
| 13 Oct 2020 | Reviewed | Reviewer Report |
| 3 Nov 2020 | Author responded | Author comments - Xiaowei Gong |
| Resubmission - Version 2 | ||
| 3 Nov 2020 | Submitted | Manuscript version 2 |
| 15 Nov 2020 | Reviewed | Reviewer Report |
| 22 Nov 2020 | Reviewed | Reviewer Report - KHALID AHMAD ALSUNAIDAR |
| 5 Jan 2021 | Reviewed | Reviewer Report |
| 27 Jan 2021 | Author responded | Author comments - Xiaowei Gong |
| Resubmission - Version 3 | ||
| 27 Jan 2021 | Submitted | Manuscript version 3 |
| 30 May 2021 | Author responded | Author comments - Xiaowei Gong |
| Resubmission - Version 4 | ||
| 30 May 2021 | Submitted | Manuscript version 4 |
| Publishing | ||
| 3 Jun 2021 | Editorially accepted | |
| 10 Jun 2021 | Article published | 10.1186/s12879-021-06282-6 |
You can find further information about peer review here.